Biology subjects

Olejniczak, S.

Publications and source records attributed to Olejniczak, S..

4 recordsLinked to original sources

bioRxiv2026

DepoCat: Interactive database of experimentally verified phage depolymerases

Klebsiella phage depolymerases degrade polysaccharide capsules and exhibit narrow substrate specificity for particular capsular types. Despite a growing number of experimentally characterized enzymes, these data remain scattered throughout the scientific literature, while existing protein sequence repositories are dominated by entries with computationally assigned, unverified functional annotations. Here we present DepoCat, the first interactive database of phage depolymerases with experimentally verified function and specificity, available at http://depocat.uwr.edu.pl. The database currently contains 131 proteins meeting rigorous inclusion criteria, spanning 75 distinct capsular types. Each entry integrates experimental and computational resources. The web interface provides an integrated Classifier tool with two search modes: sequence-based search and structure-based search - enabling preliminary structural classification and inference of putative substrate specificity of newly identified depolymerases. We demonstrated the utility of both modes on a set of 17 experimentally verified non-Klebsiella phage depolymerases, for which structural analysis enabled unambiguous class assignment in almost all cases despite low or undetectable sequence similarity to the database reference dataset. DepoCat constitutes a publicly accessible resource supporting research into the structural diversity and sequence-structure-specificity relationships of phage depolymerases, while also facilitating the identification of candidates for therapeutic and diagnostic applications.

microbiology↗

bioRxiv2025

DepoCatalog: Mapping the Diversity of 105 Recombinant Klebsiella Phage Depolymerases Across Sequence, Structure, and Substrate Specificity

A validated catalog of 105 recombinant depolymerases from Klebsiella phages covers 58 KL-types. 46 novel enzymes from prophages, jumbo phages, and common phages are linked to any known enzymatic activity against 14 classical serotypes and 12 genome-defined KL-types. Using activity-based profiling, structure prediction, and domain dissection, we developed a function-guided classification and a five-class structural catalog. This framework reveals highly specific enzymes active against up to three capsule types. K47 CPS was degraded by three diverse protein groups. Structurally similar depolymerases degrading particular CPS were found in distinct phage taxa, with highly conserved enzymes in Drulisvirus specific to K1-, K2-types. The exclusive depolymerases were found in siphoviruses targeting K2 and K62 serotypes. A case study of five structurally similar enzymes degrading KL22/KL37/KL111 and KL25/KL119 capsules suggested specificity switching via amino acid changes or C-domain modification. Klebsiella phage depolymerases catalog sheds light on their diversity, evolution, and potential application.

microbiology↗

bioRxiv2025

Capsular specificity in temperate phages of Klebsiella pneumoniae is driven by diverse receptor-binding enzymes

In bacteriophages infecting Klebsiella pneumoniae, capsule specificity is a major determinant of host range due to the presence of capsule-specific depolymerases. Yet for temperate phages, the genetic and functional basis of this specificity remains less well understood. Depolymerases appear unexpectedly rare in prophage genomes, raising unresolved questions about which prophage genes mediate capsule tropism, whether this apparent scarcity reflects biological or ecological differences versus annotation limits, and whether prophage-encoded receptor-binding proteins (RBPs) are functionally active. To address these questions, we analysed 3,900 Klebsiella genomes from diverse ecological niches to identify prophage-encoded proteins mediating capsule tropism. We conducted a genome-wide association study (GWAS) correlating prophage protein clusters (from 8,105 prophages) with confidently assigned bacterial K-loci. GWAS identified high-confidence predictors for 16 out of 35 most diverse K-loci, of which 14 were receptor-binding proteins (RBPs) belonging to classical depolymerases (n = 6), SGNH hydrolases which deacetylate polysaccharides (n = 6), and structurally novel RBPs (n = 2). Overall, we predicted K-locus specificity for 26 putative depolymerases, of which 12 were deemed as strong predictions against 10 K-loci. In parallel, we attempted recombinant production of 50 putative depolymerases selected from 469 candidate proteins identified in prophages from a representative subset of 99 bacterial isolates, together with an additional 10 depolymerases selected based on GWAS predictions. All recombinant proteins were tested against a Klebsiella reference panel of 119 K-types. Of the 50 manually chosen putative depolymerases, 34 failed to yield detectable recombinant expression, a pattern unlikely to be explained by degraded or defective prophages. Of the 14 active enzymes, 5 targeted a K-locus different from that of their bacterial host, and enzyme specificity could not always be reliably inferred from sequence similarity or structural homology. Comparison of GWAS predictions with experimental validation results revealed that 10 of the 12 strongest GWAS predictors were confirmed experimentally, while 2 produced soluble protein but showed no detectable activity against the tested K-types. Together, these results highlight the intrinsic difficulty of predicting activity and capsule specificity of prophage-encoded RBPs from genomic information alone. Finally, analysis of 4,598 high-completeness prophages revealed that SGNH-domain hydrolases are among the most prevalent enzymatic domains in prophage RBPs. Two SGNH-domain RBPs identified by GWAS were experimentally confirmed as active esterases, supporting capsule deacetylation as a widespread alternative to polysaccharide depolymerisation in temperate phages. Our findings reveal that Klebsiella prophages encode structurally diverse RBPs, suggesting temperate phages may rely not only on depolymerisation but also on capsule modification--such as deacetylation--for infection. This also implies that capsule diversity in K. pneumoniae may be substantially underestimated, with implications for phage specificity, competition and vaccine design.

microbiology↗

bioRxiv2025

p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer

Metastatic breast cancer (MBC) is a life-threatening disease with limited therapeutic options. The immune suppressive tumor microenvironment (TME) limits the potency of the antitumor immune response and facilitates disease progression and metastasis. Our current study demonstrates that p38 is a druggable target in the TME that regulates the outcome of the immune-tumor interaction. The study revealed that systemic blockade of p38 reduces metastasis, and this anti-metastatic response is negated by depletion of CD8+ T cells. Single-cell transcriptomic analysis of the immune-TME showed that pharmacological p38 inhibition (p38i) or tumor-specific inactivation of p38 by CRISPR/Cas9 (p38KO) resulted in a less exhausted and more activated CD8+ T cell phenotype. Immunophenotyping analyses demonstrated that p38 blockade reduced the expression of multiple inhibitory receptors on CD8+ T cells (i.e., PD-1, LAG-3, CTLA-4), indicating a reversal of immune exhaustion and enhanced immune activation systemically and in the TME. In contrast, p38 blockade did not exhibit inhibitory effects on T cells in proliferation assays in vitro and did not affect the proportion of regulatory T cells in vivo. The major negative impact of p38 blockade in vivo was on the myeloid populations, such as myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs). Further, tumor p38 activity was required for the expression of cytokines/chemokines and tumor-derived exosomes with high chemotactic capacity for myeloid cells. Altogether, this study highlights a previously unrecognized p38-driven pathway that promotes an immune suppressive TME and metastasis, and that therapeutic blockade of p38 has important implications for improving antitumor immunity and patient outcomes. STATEMENT OF SIGNIFICANCEThis study highlights a previously unrecognized p38-driven tumor pathway that promotes an immune suppressive microenvironment and metastasis, and that therapeutic blockade of p38 has important implications for improving antitumor immunity and patient outcomes.

cancer biology↗